Dipalmitoylphosphatidylcholine

Dipalmitoylphosphatidylcholine

Dipalmitoylphosphatidylcholine (DPPC) is a type of phospholipid that is a major component of pulmonary surfactant, the substance that reduces the surface tension in the alveoli of the lungs. DPPC is the most abundant phospholipid in pulmonary surfactant and is essential for normal respiration.

Structure and Properties

DPPC is a diacylglycerol, it contains two fatty acid chains, both palmitic acid, attached to a glycerol backbone. The third hydroxyl group of the glycerol is linked to a phosphate group, which in turn is attached to a choline molecule. This structure gives DPPC its amphipathic properties, with a hydrophilic head and hydrophobic tail, allowing it to form lipid bilayers.

The melting temperature of DPPC is approximately 41°C, which is higher than body temperature. This means that at physiological temperatures, DPPC is in a gel phase, which is less fluid than the liquid-crystalline phase of other phospholipids. This property is important for the function of DPPC in pulmonary surfactant.

Role in Pulmonary Surfactant

Pulmonary surfactant is a complex mixture of lipids and proteins that is secreted by the type II alveolar cells into the alveolar space. Its main function is to reduce the surface tension at the air-liquid interface in the alveoli, preventing their collapse at the end of expiration.

DPPC, due to its high melting temperature and ability to form a tightly packed lipid layer, is the main component responsible for the surface tension-lowering properties of pulmonary surfactant. It is thought that DPPC forms a condensed monolayer at the air-liquid interface, reducing the surface tension and allowing for gas exchange to occur.

Clinical Significance

Deficiency or dysfunction of DPPC can lead to RDS, a condition that can cause severe breathing difficulties. This is often seen in premature infants, whose lungs have not yet fully developed and are unable to produce sufficient amounts of surfactant. In such cases, surfactant replacement therapy, often containing DPPC, can be used to treat the condition.

Resources

Latest articles - Dipalmitoylphosphatidylcholine

• Most recent articles
• Ongoing trials

Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Dipalmitoylphosphatidylcholine for any updates.

‎